How Hims & Hers Delivers Safe & Affordable Access to GLP-1 Injections

June 6, 2024

As we continue our work to bring world class, personalized care to more people, our priority remains on the safety and success of each of our customers.

download button

As we continue our work to bring world class, personalized care to more people, our priority remains on the safety and success of each of our customers.

Download image
We are thrilled to now offer access to GLP-1 medications, in addition to oral weight loss medication kits and branded medications through the Hims & Hers platform. We believe the compounding of GLP-1 injections can help bring safe and affordable weight loss options to more customers struggling with obesity.

We never prioritize being first to market, but instead, always aim to offer an affordable, safe, and effective solution for our customers that meets the high standards they’ve come to expect from us. Delivering on our vision for safe and affordable access to GLP-1 injections took us over a year because our diligence required vetting dozens of manufacturers across the country with a wide range of expertise and safety standards. We hold ourselves and our partners to the most stringent standards in the market, and it was imperative we identified a partner aligned with our best in class standards. 

Giving confidence and peace of mind to our customers and community is important, so we’re sharing the standards we adhere to at Hims & Hers to ensure the safety and quality of our offerings. While in some cases these standards go beyond what may be required by law, we believe that they raise the bar in helping instill trust and confidence in our offerings. 

Hims & Hers Safety Standards for Compounded GLP-1 Injections
  • Formulated in Industry-Leading Facilities: To ensure customers feel confident in the products they receive during this period of acute demand, any compounded GLP-1 medications available through our platform are produced exclusively in FDA-regulated 503B facilities in the United States. While applicable law does not require this, we believe the rigorous oversight 503B facilities are subject to, including the requirement that they follow current good manufacturing practices, helps ensure customer trust during this period.
  • Ingredients Are Sourced Exclusively from FDA-Regulated Manufacturers: Ensuring product validity, concentration and consistency is table stakes. Our partners source all active ingredients exclusively from FDA-regulated suppliers.
  • Medications Are Tested for Consistency & Quality: Each batch of medications produced are independently tested for sterility, content, and amount of active ingredients to ensure the enclosed product matches what is specified on the label. Certifications of Analysis (CoA) which validate each of these metrics are readily available upon request.
  • Temperature Controlled Storage & Shipping: GLP-1 injections are produced at our partner facilities under temperature-controlled supply chains consisting of refrigerated production, storage, and distribution facilities. Medications are always shipped under controlled temperatures necessary to ensure the treatments stay within their shelf stable temperature range. In warmer months especially, ice packs are included to ensure shelf stability in regions where necessary. 
  • Sterile, Single-Use Injections: With every shipment, customers receive the necessary number of single-use sterile syringes and alcohol swabs for safe self-administration of the medication. Educational materials on how to administer safely, along with information regarding side effects, are always included.
  • Adverse Events Tracking & Procedures: At any point, our customers can report side effects and adverse reactions, helping ensure our partner production facilities are informed in a timely manner. These procedures allow for timely investigations and incident reporting within the appropriate timelines established by the FDA.

We’ve offered access to personalized medicine through compounding for nearly 6 years as a way to help providers individualize care to meet customer needs. We’ve found both customers and providers love this flexibility, as it allows for nuanced clinical decision-making that we believe is at the core of helping customers stick to medication regimens and supporting successful outcomes.

Today, we are helping more than 1.7 million customers treat a chronic illness impacting their life, and over 600,000 of those customers are being treated with a personalized treatment regiment. Operating at this scale requires a commitment to safety at the highest levels, as well as a commitment to finding the most reliable ways of passing value back to our customers – both in their wallet and in the outcomes they achieve. 

We are committed to going above and beyond when it comes to safety. Being a partner in our customers' health and wellness journeys is a responsibility we take seriously. As we continue our work to bring world class, personalized care to more people, our priority remains on the safety and success of each of our customers.

Press Resources

Assets

Download

Contact

Abby Reisinger

press@forhims.com